Novavax
(NASDAQ) NVAX
Novavax Financials at a Glance
Market Cap
$1.59B
Revenue (TTM)
$1.12B
Net Income (TTM)
$440.30M
EPS (TTM)
$2.38
P/E Ratio
4.09
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Price
$9.61
Volume
105,559
Open
$9.83
Price
$9.61
Volume
105,559
Open
$9.83
Previous Close
$9.61
Daily Range
$9.42 - $10.00
52-Week Range
$5.01 - $11.97
Dividend
$0.00
Beta (Volatility)
1.82 (High)
Price
$9.61
Volume
105,559
Open
$9.83
Previous Close
$9.61
Daily Range
$9.42 - $10.00
52-Week Range
$5.01 - $11.97
NVAX News
How Bad Is This News for Novavax?
NVAX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Novavax
Industry
Biotechnology
Sector
Health CareEmployees
749
CEO
John C.s Jacobs, MBA
Website
www.novavax.comHeadquarters
Gaithersburg, MD 20878, US
NVAX Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
41%
Net Income Margin
39%
Return on Equity
0%
Return on Capital
65%
Return on Assets
37%
Earnings Yield
24.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.59B
Shares Outstanding
162.94M
Volume
105.56K
Short Interest
0.00%
Avg. Volume
5.02M
Financials (TTM)
Gross Profit
$1.05B
Operating Income
$563.27M
EBITDA
$492.33M
Operating Cash Flow
$244.63M
Capital Expenditure
$5.56M
Free Cash Flow
$250.19M
Cash & ST Invst.
$735.08M
Total Debt
$248.81M
Novavax Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$147.14M
+66.6%
Gross Profit
$121.94M
+136.1%
Gross Margin
82.87%
N/A
Market Cap
$1.59B
N/A
Market Cap/Employee
$1.67M
N/A
Employees
952
N/A
Net Income
$17.53M
+121.6%
EBITDA
$28.85M
+154.0%
Quarterly Fundamentals
Net Cash
$486.27M
-29.8%
Accounts Receivable
$106.45M
-1.7%
Inventory
$11.54M
+32.0%
Long Term Debt
$246.30M
+10.2%
Short Term Debt
$2.51M
-64.2%
Return on Assets
37.42%
N/A
Return on Invested Capital
64.78%
N/A
Free Cash Flow
$41.55M
+76.3%
Operating Cash Flow
$39.48M
+77.2%